Recommended IV Antibiotics for Open Fractures
For open fractures, use cefazolin (or clindamycin if penicillin-allergic) for all types, and add gram-negative coverage with piperacillin-tazobactam (preferred) or an aminoglycoside for Gustilo-Anderson Type III fractures. 1
Antibiotic Selection Algorithm
For Gustilo-Anderson Type I and II Fractures:
- First-line: Cefazolin IV
- If penicillin allergy: Clindamycin IV
- Duration: Single dose to 24 hours maximum 1, 2
The 2023 AAOS guidelines provide strong evidence that simple gram-positive coverage is sufficient for lower-grade open fractures 1. The 2022 Surgical Infection Society guidelines reinforce this, recommending against extended-spectrum coverage for Type I/II fractures as it provides no additional benefit in reducing infections, length of stay, or mortality 2.
For Gustilo-Anderson Type III Fractures:
- First-line: Cefazolin PLUS piperacillin-tazobactam
- Alternative: Cefazolin PLUS gentamicin (though piperacillin-tazobactam is preferred) 1
- If penicillin allergy: Clindamycin PLUS aztreonam or aminoglycoside 3
- Duration: Maximum 24 hours after wound closure, not to exceed 72 hours total 1, 2, 4
Important: Adding vancomycin or gentamicin to piperacillin-tazobactam does not appear helpful and increases toxicity risk 1.
Critical Timing Considerations
Antibiotics must be administered as soon as possible after injury, ideally within 3 hours 4. While the traditional "6-hour rule" has been debated, earlier administration correlates with better outcomes 5. The evidence does not support delaying surgery beyond 24 hours for most open fractures 1.
Key Evidence Synthesis
The 2023 AAOS guidelines achieved a strong recommendation for the antibiotic regimen described above, based on convincing evidence that this approach balances infection prevention with antibiotic stewardship 1. Notably, the guidelines explicitly state that adding aminoglycosides like gentamicin to piperacillin-tazobactam provides no additional benefit and increases nephrotoxicity risk.
A 2014 study demonstrated that implementing this evidence-based protocol significantly reduced aminoglycoside and glycopeptide use (from 53.5% to 16.4%) without increasing infection rates 3. This supports the narrow-spectrum approach for Type I/II fractures and selective gram-negative coverage for Type III.
Common Pitfalls to Avoid
- Do not routinely add vancomycin for MRSA coverage unless the patient is a documented MRSA carrier or has farm-related contamination 1, 2
- Do not extend antibiotics beyond 24 hours post-closure in the absence of clinical infection—this increases resistance and C. difficile risk without reducing infections 1, 2
- Do not use aminoglycosides as monotherapy for gram-negative coverage; piperacillin-tazobactam is superior and safer 1
- Do not delay antibiotic administration waiting for fracture grading—start gram-positive coverage immediately and escalate if needed 5, 6
Adjunctive Local Antibiotic Strategies
Consider adding local antibiotic delivery (moderate strength recommendation) 1:
- Vancomycin powder
- Tobramycin-impregnated beads
- Gentamicin-coated intramedullary nails
These adjuncts may provide additional benefit, particularly in Type III fractures with bone loss 2.